Abstract
Absence of polar body formation, or premature chromatin condensation (PCC) in human oocytes can cause infertility. We studied in-vitro maturing mouse oocytes in order to identify risk factors for such conditions, and for the precocious segregation of homologues or chromatids. Treatment with the actin-binding drug cytochalasin D (10 micrograms/ml) arrested oocytes in metaphase I. Upon exposure to Ca(2+)-ionophores, anaphase I was triggered in the absence of cytokinesis. Chiasmata resolved and homologues separated instantaneously. In some oocytes predivision of all chromatids occurred. Homologues or chromatids never separated even after exposure to Ca(2+)-ionophores when microtubules were depolymerized, although bivalents could eventually decondense. Thus, in meiosis I checkpoints exist which ensure that homologue separation only takes place when a metaphase I spindle is present but cytokinesis and anaphase progression can be uncoupled. Cycloheximide induced a sequential separation of homologues in oocytes with intact metaphase I spindle, resulting in metaphase II chromosomes and bivalents in individual cells as also found in some human oocytes of aged females. In oocytes which progressed to metaphase II but failed to extrude a first polar body, the two sets of chromosomes eventually aligned on a common spindle ('diploid' metaphase II). PCC of one set was never observed. Ageing in vitro of cytochalasin D-blocked metaphase I oocytes had no pronounced effect on chromosome segregation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.